Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review

Detalhes bibliográficos
Autor(a) principal: Bandovas, JP
Data de Publicação: 2022
Outros Autores: Leal, B, Reis‐de‐Carvalho, C, Sousa, DC, Araújo, JC, Peixoto, P, Henriques, SO, Vaz Carneiro, A
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4343
Resumo: Medical overuse-defined as the provision of health services for which potential harms exceed potential benefits-constitutes a paradigm of low-value care and is seen as a threat to the quality of care. Value in healthcare implies a precise definition of disease. However, defining a disease may not be straightforward since clinical data do not show discrete boundaries, calling for some clinical judgment. And, if in time a redefinition of disease is needed, it is important to recognize that it can induce overdiagnosis, the identification of medical conditions that would, otherwise, never cause any significant symptoms or lead to clinical harm. A classic example is the impact of recommendations from professional societies in the late 1990s, lowering the threshold for abnormal total cholesterol from 240 mg/dl to 200 mg/dl. Due to these changes in risk factor definition, literally overnight there were 42 million new cases eligible for treatment in the United States. The same happened with hypertension-using either the 2019 NICE guidelines or the 2018 ESC/ECC guidelines criteria for arterial hypertension, the proportion of people overdiagnosed with hypertension was calculated to be between 14% and 33%. In this review, we will start by discussing resource overuse. We then present the basis for disease definition and its conceptual problems. Finally, we will discuss the impact of changing risk factor/disease definitions in the prevalence of disease and its consequences in overdiagnosis and overtreatment (a problem particularly relevant when definitions are widened to include earlier or milder disease).
id RCAP_16add15cb4e7d5078c4ce79c232fef4d
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4343
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative ReviewChanging risk factor/disease definitionsDisease/definitionLow-value careOverdiagnosisOvertreatmenResource overuseHCC CIRMedical overuse-defined as the provision of health services for which potential harms exceed potential benefits-constitutes a paradigm of low-value care and is seen as a threat to the quality of care. Value in healthcare implies a precise definition of disease. However, defining a disease may not be straightforward since clinical data do not show discrete boundaries, calling for some clinical judgment. And, if in time a redefinition of disease is needed, it is important to recognize that it can induce overdiagnosis, the identification of medical conditions that would, otherwise, never cause any significant symptoms or lead to clinical harm. A classic example is the impact of recommendations from professional societies in the late 1990s, lowering the threshold for abnormal total cholesterol from 240 mg/dl to 200 mg/dl. Due to these changes in risk factor definition, literally overnight there were 42 million new cases eligible for treatment in the United States. The same happened with hypertension-using either the 2019 NICE guidelines or the 2018 ESC/ECC guidelines criteria for arterial hypertension, the proportion of people overdiagnosed with hypertension was calculated to be between 14% and 33%. In this review, we will start by discussing resource overuse. We then present the basis for disease definition and its conceptual problems. Finally, we will discuss the impact of changing risk factor/disease definitions in the prevalence of disease and its consequences in overdiagnosis and overtreatment (a problem particularly relevant when definitions are widened to include earlier or milder disease).WileyRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEBandovas, JPLeal, BReis‐de‐Carvalho, CSousa, DCAraújo, JCPeixoto, PHenriques, SOVaz Carneiro, A2022-12-29T13:03:56Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4343engJ Intern Med . 2022 Apr;291(4):426-43710.1111/joim.13465info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:46:14Zoai:repositorio.chlc.min-saude.pt:10400.17/4343Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:40.276075Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
title Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
spellingShingle Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
Bandovas, JP
Changing risk factor/disease definitions
Disease/definition
Low-value care
Overdiagnosis
Overtreatmen
Resource overuse
HCC CIR
title_short Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
title_full Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
title_fullStr Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
title_full_unstemmed Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
title_sort Broadening Risk Factor or Disease Definition as a Driver for Overdiagnosis: A Narrative Review
author Bandovas, JP
author_facet Bandovas, JP
Leal, B
Reis‐de‐Carvalho, C
Sousa, DC
Araújo, JC
Peixoto, P
Henriques, SO
Vaz Carneiro, A
author_role author
author2 Leal, B
Reis‐de‐Carvalho, C
Sousa, DC
Araújo, JC
Peixoto, P
Henriques, SO
Vaz Carneiro, A
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Bandovas, JP
Leal, B
Reis‐de‐Carvalho, C
Sousa, DC
Araújo, JC
Peixoto, P
Henriques, SO
Vaz Carneiro, A
dc.subject.por.fl_str_mv Changing risk factor/disease definitions
Disease/definition
Low-value care
Overdiagnosis
Overtreatmen
Resource overuse
HCC CIR
topic Changing risk factor/disease definitions
Disease/definition
Low-value care
Overdiagnosis
Overtreatmen
Resource overuse
HCC CIR
description Medical overuse-defined as the provision of health services for which potential harms exceed potential benefits-constitutes a paradigm of low-value care and is seen as a threat to the quality of care. Value in healthcare implies a precise definition of disease. However, defining a disease may not be straightforward since clinical data do not show discrete boundaries, calling for some clinical judgment. And, if in time a redefinition of disease is needed, it is important to recognize that it can induce overdiagnosis, the identification of medical conditions that would, otherwise, never cause any significant symptoms or lead to clinical harm. A classic example is the impact of recommendations from professional societies in the late 1990s, lowering the threshold for abnormal total cholesterol from 240 mg/dl to 200 mg/dl. Due to these changes in risk factor definition, literally overnight there were 42 million new cases eligible for treatment in the United States. The same happened with hypertension-using either the 2019 NICE guidelines or the 2018 ESC/ECC guidelines criteria for arterial hypertension, the proportion of people overdiagnosed with hypertension was calculated to be between 14% and 33%. In this review, we will start by discussing resource overuse. We then present the basis for disease definition and its conceptual problems. Finally, we will discuss the impact of changing risk factor/disease definitions in the prevalence of disease and its consequences in overdiagnosis and overtreatment (a problem particularly relevant when definitions are widened to include earlier or milder disease).
publishDate 2022
dc.date.none.fl_str_mv 2022-12-29T13:03:56Z
2022
2022-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4343
url http://hdl.handle.net/10400.17/4343
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv J Intern Med . 2022 Apr;291(4):426-437
10.1111/joim.13465
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131311806349312